The structural profiles are close, with Medpace carrying a narrow edge on stability. DexCom still has the edge on valuation, which keeps the comparison from looking entirely one-sided. On the market side, Medpace is in better shape — its trend is intact while DexCom's trend has broken down. That puts structure and market broadly in agreement — Medpace's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
Most of the separation is still concentrated in stability.
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
Most of the shared profile comes through margin consistency and revenue growth trajectory.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in stability.
Left means cheaper relative valuation. Higher means stronger structure.
Structure stays fairly close here, while current pricing still looks more supportive for DexCom, Inc..
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where DXCM and MEDP each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The stability gap is visible, with the stronger side looking materially steadier through time.
Absolute pricing still looks more supportive for DexCom, with a forward P/E that is 6.6 turns lower there.
Stability is the clearest driver of the lead, with valuation adding further support — though valuation still provides a real counterweight.
Break down the DXCM vs MEDP comparison across all dimensions with the full interactive tool.
Explore how DXCM and MEDP each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.